Akinsheye, I., Alsultan, A., Solovieff, Ngo, D., Baldwin, C. T., Paola, S., Chui, D. K, & Steinberg, M. H. Fetal hemoglobin in sickle cell anemia. Blood, 118, 19-27. doi: https://doi.org/10.1182/blood-2011-03-325258. Centers for Disease Control and Prevention. (2016). Sickle cell disease: Statistics & data. Retrieved from: http://www.cdc.gov/NCBDDD/sicklecell/data.html. DeBaun, M. R., & Vichinsky, E. P. (2016). Red blood cell transfusion in sickle cell disease. In S. L. Shrier & D. H. Mahoney (Eds.), UpToDate. Waltham, MA. Lexi Comp Online. Lexi-Drugs, Hudson, Ohio; December 29, 2016. National Heart, Lung, and Blood Institute. (2014). Evidence based manage of sickle cell disease. Retrieved from: https://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/sickle-cell-disease-report.pdf. National Heart, Lung, and Blood Institute. (2014). The management of sickle cell disease. Retrieved from: https://www.nhlbi.nih.gov/files/docs/guidelines/sc_mngt.pdf. National Heart, Lung, and Blood Institute. (2016). What is sickle cell disease. Retrieved from: https://www.nhlbi.nih.gov/health/health-topics/topics/sca. Rodgers, G. P. (2016). Hydroxyurea and other disease-modifying therapies in sickle cell disease In S. L. Shrier & D. H. Mahoney (Eds.), UpToDate. Waltham, MA. Schrier, S. L., & Bacon, B. R. (2016). Chelation therapy for thalassemia and other iron overload states. In W. C. Mentzer (Ed.), UpToDate. Waltham, MA. Singh, R., Jordan, R., & Hanlon, C. (2014). Economic impact of sickle cell hospitalization. Blood, 124 (21),5971. Steinberg, M. H., Chui, D. H., Dover, G. J., Sebastiani, P., & Alsultan, A. (2013). Fetal hemoglobin in sickle cell anemia: A glass half full. Blood 123, 481-485. doi: https://doi.org/10.1182/blood-2013-09-528067. Steinberg, M. H. (2016). Fetal hemoglobin (hemoglobin F) in health and disease. In W. C. Mentzer (Ed.)., UpToDate. Waltham, MA. |